Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
| 2 |
UDR
UDR
|
+$344M |
| 3 |
Alexandria Real Estate Equities
ARE
|
+$333M |
| 4 |
Invitation Homes
INVH
|
+$326M |
| 5 |
Tesla
TSLA
|
+$271M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$976M |
| 3 |
Citigroup
C
|
+$352M |
| 4 |
Linde
LIN
|
+$351M |
| 5 |
Microsoft
MSFT
|
+$331M |
Sector Composition
| 1 | Technology | 23.31% |
| 2 | Financials | 14.41% |
| 3 | Healthcare | 12.63% |
| 4 | Consumer Discretionary | 12.55% |
| 5 | Communication Services | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Forrester Research
FORR
$188M
| $4.31M | ﹤0.01% |
94,172
| – | – |
|
1927
Weibo
WB
$2.98B
| $4.31M | ﹤0.01% |
81,828
-235,425
| -74% | -$12.4M |
|
|
RUBY
1928
DELISTED
Rubius Therapeutics, Inc
RUBY
| $4.26M | ﹤0.01% |
174,519
-205,481
| -54% | -$5.02M |
|
|
VCRA
1929
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $4.24M | ﹤0.01% |
106,346
| – | – |
|
1930
Axsome Therapeutics
AXSM
$6.19B
| $4.2M | ﹤0.01% |
62,223
-145,699
| -70% | -$9.83M |
|
1931
Broadstone Net Lease
BNL
$3.52B
| $4.15M | ﹤0.01% |
177,203
-72,501
| -29% | -$1.7M |
|
1932
Myers Industries
MYE
$602M
| $4.14M | ﹤0.01% |
197,049
-77,744
| -28% | -$1.63M |
|
1933
Integral Ad Science
IAS
$1.41B
| $4.12M | ﹤0.01% |
+200,000
| New | +$4.12M |
|
|
CERE
1934
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.07M | ﹤0.01% |
+158,852
| New | +$4.07M |
|
|
EVLO
1935
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $4.04M | ﹤0.01% |
14,712
| – | – |
|
1936
Esperion Therapeutics
ESPR
$524M
| $4.02M | ﹤0.01% |
189,931
-38,012
| -17% | -$804K |
|
1937
Republic Bancorp
RBCAA
$1.49B
| $3.98M | ﹤0.01% |
86,303
| – | – |
|
1938
Design Therapeutics
DSGN
$349M
| $3.98M | ﹤0.01% |
200,000
| – | – |
|
1939
Jamf
JAMF
$1.3B
| $3.94M | ﹤0.01% |
117,436
| – | – |
|
1940
Lantheus
LNTH
$3.57B
| $3.94M | ﹤0.01% |
+142,500
| New | +$3.94M |
|
1941
Amneal Pharmaceuticals
AMRX
$3.08B
| $3.9M | ﹤0.01% |
761,253
-46,653
| -6% | -$239K |
|
1942
StepStone Group
STEP
$4.81B
| $3.89M | ﹤0.01% |
113,200
+68,200
| +152% | +$2.35M |
|
1943
Green Plains
GPRE
$635M
| $3.74M | ﹤0.01% |
111,200
-105,100
| -49% | -$3.53M |
|
1944
Wabash National
WNC
$461M
| $3.61M | ﹤0.01% |
+225,400
| New | +$3.61M |
|
|
ACCD
1945
DELISTED
Accolade, Inc. Common Stock
ACCD
| $3.59M | ﹤0.01% |
66,115
+26,115
| +65% | +$1.42M |
|
1946
Allot
ALLT
$397M
| $3.55M | ﹤0.01% |
180,039
+15,757
| +10% | +$311K |
|
1947
Neuronetics
STIM
$228M
| $3.47M | ﹤0.01% |
+216,600
| New | +$3.47M |
|
|
CSPR
1948
DELISTED
Casper Sleep Inc.
CSPR
| $3.42M | ﹤0.01% |
+414,403
| New | +$3.42M |
|
1949
Children's Place
PLCE
$170M
| $3.4M | ﹤0.01% |
36,489
-94,300
| -72% | -$8.78M |
|
1950
Montrose Environmental
MEG
$1.02B
| $3.39M | ﹤0.01% |
+63,200
| New | +$3.39M |
|